• Je něco špatně v tomto záznamu ?

Building Kidney Exchange Programmes in Europe-An Overview of Exchange Practice and Activities

P. Biró, B. Haase-Kromwijk, T. Andersson, EI. Ásgeirsson, T. Baltesová, I. Boletis, C. Bolotinha, G. Bond, G. Böhmig, L. Burnapp, K. Cechlárová, P. Di Ciaccio, J. Fronek, K. Hadaya, A. Hemke, C. Jacquelinet, R. Johnson, R. Kieszek, DR. Kuypers,...

. 2019 ; 103 (7) : 1514-1522. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, systematický přehled

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023878

BACKGROUND: Considerable differences exist among the living donor Kidney Exchange Programmes (KEPs) that are in use and being built in Europe, contributing to a variation in the number of living donor transplants (Newsletter Transplant; International figures on donation and transplantation 2016). Efforts of European KEPs to exchange (best) practices and share approaches to address challenges have, however, been limited. METHODS: Experts from 23 European countries, collaborating on the European Network for Collaboration on Kidney Exchange Programmes Cooperation on Science and Technology Action, developed a questionnaire to collect detailed information on the functioning of all existing KEPs in Europe, as well as their opportunities and challenges. Following a comparative analysis, results were synthesized and interpreted by the same experts. RESULTS: The practices, opportunities and challenges reported by 17 European countries reveal that some of the 10 operating programs are mature, whereas others are in earlier stages of development. Over 1300 transplants were performed through existing KEPs up to the end of 2016, providing approximately 8% of their countries' living kidney donations in 2015. All countries report challenges to either initiating KEPs or increasing volumes. Some challenges are shared, whereas others differ because of differences in context (eg, country size, effectiveness of deceased donor program) and ethical and legal considerations (eg, regarding living donation as such, nonrelated donors, and altruistic donation). Transnational initiatives have started in Central Europe, Scandinavia, and Southern Europe. CONCLUSIONS: Exchange of best practices and shared advancement of national programs to address existing challenges, aided by transnational exchanges, may substantially improve access to the most (cost) effective treatment for the increasing number of patients suffering from kidney disease.

Agence de la Biomedecine Saint Denis France

Department of Computer Science University College Cork Cork Ireland

Department of Economics Lund University Lund Sweden

Department of Nephrology and Renal Transplantation University Hospitals Leuven Belgium

Department of Political and Economic Studies University of Helsinki Helsinki Finland

Division of Nephrology and Dialysis Department of Medicine 3 Medical University of Vienna Vienna Austria

Division of Nephrology and Transplantation Geneva University Hospitals Geneva Switzerland

Dutch Transplantation Foundation Leiden the Netherlands

HEC Management School Université de Liege Liege Belgium

Hellenic Transplant Organization Athens Greece

Institute for Clinical and Experimental Medicine Prague Czech Republic

Institute of Economics Hungarian Academy of Sciences Budapest Hungary

Institute of Mathematics P J Safarik University Košice Slovakia

Instituto Portugues do Sangue e da Transplantacao Lisbon Portugal

Italian National Transplant Centre Rome Italy

Medical University of Warsaw Warsaw Poland

National Health Service Blood and Transplant Bristol United Kingdom

Nephrology Department Laikon Hospital Athens Greece

Organización Nacional de Trasplantes Madrid Spain

Prince Mohammad Bin Salman College King Abdullah Economic City Kingdom of Saudi Arabia

School of Computing Sciences University of Glasgow Glasgow United Kingdom

School of Science and Engineering Reykjavik University Reykjavik Iceland

Transplant Center L Pasteur's University Hospital Košice Slovakia

United Network for Organ Sharing Richmond VA

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023878
003      
CZ-PrNML
005      
20201214131534.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/TP.0000000000002432 $2 doi
035    __
$a (PubMed)30247314
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Biró, Péter $u Institute of Economics, Hungarian Academy of Sciences, Budapest, Hungary.
245    10
$a Building Kidney Exchange Programmes in Europe-An Overview of Exchange Practice and Activities / $c P. Biró, B. Haase-Kromwijk, T. Andersson, EI. Ásgeirsson, T. Baltesová, I. Boletis, C. Bolotinha, G. Bond, G. Böhmig, L. Burnapp, K. Cechlárová, P. Di Ciaccio, J. Fronek, K. Hadaya, A. Hemke, C. Jacquelinet, R. Johnson, R. Kieszek, DR. Kuypers, R. Leishman, MA. Macher, D. Manlove, G. Menoudakou, M. Salonen, B. Smeulders, V. Sparacino, FCR. Spieksma, MO. Valentín, N. Wilson, J. van der Klundert, ENCKEP COST Action,
520    9_
$a BACKGROUND: Considerable differences exist among the living donor Kidney Exchange Programmes (KEPs) that are in use and being built in Europe, contributing to a variation in the number of living donor transplants (Newsletter Transplant; International figures on donation and transplantation 2016). Efforts of European KEPs to exchange (best) practices and share approaches to address challenges have, however, been limited. METHODS: Experts from 23 European countries, collaborating on the European Network for Collaboration on Kidney Exchange Programmes Cooperation on Science and Technology Action, developed a questionnaire to collect detailed information on the functioning of all existing KEPs in Europe, as well as their opportunities and challenges. Following a comparative analysis, results were synthesized and interpreted by the same experts. RESULTS: The practices, opportunities and challenges reported by 17 European countries reveal that some of the 10 operating programs are mature, whereas others are in earlier stages of development. Over 1300 transplants were performed through existing KEPs up to the end of 2016, providing approximately 8% of their countries' living kidney donations in 2015. All countries report challenges to either initiating KEPs or increasing volumes. Some challenges are shared, whereas others differ because of differences in context (eg, country size, effectiveness of deceased donor program) and ethical and legal considerations (eg, regarding living donation as such, nonrelated donors, and altruistic donation). Transnational initiatives have started in Central Europe, Scandinavia, and Southern Europe. CONCLUSIONS: Exchange of best practices and shared advancement of national programs to address existing challenges, aided by transnational exchanges, may substantially improve access to the most (cost) effective treatment for the increasing number of patients suffering from kidney disease.
650    _2
$a benchmarking $x organizace a řízení $7 D019985
650    12
$a kooperační chování $7 D003299
650    _2
$a integrované poskytování zdravotní péče $x organizace a řízení $7 D019033
650    _2
$a disparity zdravotní péče $x organizace a řízení $7 D054625
650    _2
$a lidé $7 D006801
650    12
$a mezinárodní spolupráce $7 D007391
650    12
$a transplantace ledvin $7 D016030
650    12
$a žijící dárci $7 D019520
650    _2
$a vytváření politiky $7 D011050
650    _2
$a rozvoj plánování $7 D016730
650    _2
$a hodnocení programu $7 D015397
650    _2
$a získávání tkání a orgánů $x organizace a řízení $7 D009927
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a systematický přehled $7 D000078182
700    1_
$a Haase-Kromwijk, Bernadette $u Dutch Transplantation Foundation, Leiden, the Netherlands.
700    1_
$a Andersson, Tommy $u Department of Economics, Lund University, Lund, Sweden.
700    1_
$a Ásgeirsson, Eyjólfur Ingi $u School of Science and Engineering, Reykjavik University, Reykjavik, Iceland.
700    1_
$a Baltesová, Tatiana $u Transplant Center, L. Pasteur's University Hospital, Košice, Slovakia.
700    1_
$a Boletis, Ioannis $u Nephrology Department, Laikon Hospital, Athens, Greece.
700    1_
$a Bolotinha, Catarina $u Instituto Portugues do Sangue e da Transplantacao, Lisbon, Portugal.
700    1_
$a Bond, Gregor $u Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
700    1_
$a Böhmig, Georg $u Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
700    1_
$a Burnapp, Lisa $u National Health Service Blood and Transplant, Bristol, United Kingdom.
700    1_
$a Cechlárová, Katarína $u Institute of Mathematics, P.J. Safarik University, Košice, Slovakia.
700    1_
$a Di Ciaccio, Paola $u Italian National Transplant Centre, Rome, Italy.
700    1_
$a Fronek, Jiri $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Hadaya, Karine $u Division of Nephrology and Transplantation, Geneva University Hospitals, Geneva, Switzerland.
700    1_
$a Hemke, Aline $u Dutch Transplantation Foundation, Leiden, the Netherlands.
700    1_
$a Jacquelinet, Christian $u Agence de la Biomedecine, Saint-Denis, France.
700    1_
$a Johnson, Rachel $u National Health Service Blood and Transplant, Bristol, United Kingdom.
700    1_
$a Kieszek, Rafal $u Medical University of Warsaw, Warsaw, Poland.
700    1_
$a Kuypers, Dirk R $u Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Belgium.
700    1_
$a Leishman, Ruthanne $u United Network for Organ Sharing (UNOS), Richmond. VA.
700    1_
$a Macher, Marie-Alice $u Agence de la Biomedecine, Saint-Denis, France.
700    1_
$a Manlove, David $u School of Computing Sciences, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Menoudakou, Georgia $u Hellenic Transplant Organization, Athens, Greece.
700    1_
$a Salonen, Mikko $u Department of Political and Economic Studies, University of Helsinki, Helsinki, Finland.
700    1_
$a Smeulders, Bart $u HEC Management School, Université de Liege, Liege, Belgium.
700    1_
$a Sparacino, Vito $u Italian National Transplant Centre, Rome, Italy.
700    1_
$a Spieksma, Frits C R $u Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Belgium.
700    1_
$a Valentín, María Oliva $u Organización Nacional de Trasplantes, Madrid, Spain.
700    1_
$a Wilson, Nic $u Department of Computer Science, University College Cork, Cork, Ireland.
700    1_
$a van der Klundert, Joris $u Prince Mohammad Bin Salman College, King Abdullah Economic City, Kingdom of Saudi Arabia.
710    2_
$a ENCKEP COST Action
773    0_
$w MED00010695 $t Transplantation $x 1534-6080 $g Roč. 103, č. 7 (2019), s. 1514-1522
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30247314 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214131531 $b ABA008
999    __
$a ok $b bmc $g 1596197 $s 1114554
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 103 $c 7 $d 1514-1522 $e - $i 1534-6080 $m Transplantation $n Transplantation $x MED00010695
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace